In a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of lung cancer.
Nancy DeMore, M.D. is leading a clinical trial using frankincense to try to treat breast and colon cancer at the Medical University of South Carolina. The study was inspired by a research specialist in DeMore’s lab.
Nancy DeMore, M.D. teamed up with Clemson engineering students to work on a device that will improve patient experience and lower costs.
The new generation of surgical learners are poised to move the field into the next era and require unique and innovative methods of learning to do so.
We are committed to empowering the surgeons of tomorrow to continue to deliver compassionate patient care as they face the extraordianry challenges of the next evolution of surgical training.
Support resident education and empower the next generation of surgeons.
With one of the strongest transplant programs in the nation and the only living donor transplant center in the state, we have achieved much in our short history. Groundbreaking research developments are paving the way for new discoveries that will vastly improve patient care and outcomes. Still, barriers persist. Each day 22 people die waiting for an organ transplant. More than 120,000 people currently await transplant nationwide, including more than 1,000 in South Carolina. More than 85 percent of those people need a kidney transplant, and the numbers continue to grow.
The MUSC Living Donor Institute aims to improve education and access, recruite and retain the world’s best transplant team and embrace innovation and collaboration in research to Change What's Possible for patients in need of organ transplantation.
Endowed Chairs are the highest academic award that we bestow on a faculty member, and it lasts as long as the University exists. Thus, it honors both the donor and the accomplished recipient by helping the next generation of surgical leaders achieve their full potential.
The David B. Adams Endowed Chair in GI and Laparoscopy Surgery is named in David B. Adams, M.D. honor and will be held by the Division Chief of GI and Laparoscopic Surgery.
"A class act in every dimension ...Truly exceptional ...Genuinely kind, selfless ... Always rooting for the underdog ... No one in the field of Surgery is a better example of a master surgical educator ... He routinely gives hope to the hopeless ... The consummate surgeon."
These are but a few of the moving tributes shared in describing Dr. David Adams, who joined the faculty in the Department of Surgery at MUSC in 1986. He has served as Medical Director, One West Trauma Center, Program Director in the General Surgery Residency Training Program, Interim Chairman of the Department, Chief of the Division of GI and Laparoscopic Surgery and has just stepped down from his 27th consecutive year as Course Director of the highly-praised MUSC Annual Postgraduate Course in Surgery.
The Elliott-Robison Endowed Chair in Vascular Surgery honors two accomplished leaders whose numerous contributions have contributed to nationally recognized and improved care of patients with vascular diseases - not only in South Carolina - but throughout the world.
Bruce M Elliott, M.D. has served many leadership roles including President of the Medical staff, President of the University Medical Associates faculty practice plan, Sr. Associate Dean for Clinical Affairs, and the University’s designated Conflict of Interest officer. Dr. Elliott’s clinical interests have focused on Carotid Disease, Diabetic foot, and Aortic Aneurysms.
Jacob Robison, M.D. has been an advocate of adapting new technologies to the assessment and management of vascular disease. Together with his associates in interventional radiology, he pioneered the management of aortic aneurysms with endovascular stent grafting in South Carolina in 1996. He also performed the first fenestrated aortic graft involving physician modification to preserve renal blood flow during EVAR and performed the first four-vessel fenestrated EVAR in South Carolina.
As we contintue to create a bedside-to-bench and back again culture of discovery and innovation at MUSC, we want all investigators — from clinical to basic science — to have the resources they need to advance their science. Supporting our research will allow our surgeon-scientists to pave the way for new discoveries that will improve patient care. Additionally, one of the strengths of the residency program is the opportunity to participate in clinical and basic science research. Your gift will also make it possible for a surgical resident to conduct a truly exceptional research project, potentially furthering his or her career.
As global health becomes more successful and fewer people are dying of malnutrition and communicable diseases, the burden of Global Surgery will create new challenges. Our global outreach in Cameroon provides a robust training opportunity for our residents to meet and work with African surgeons and residents who are training to work in their own countries. This international rotation is invaluable to our U.S. residents as they learn how they can make a difference in this rapidly changing and interconnected world.